SUBLIMAZE

This brand name is authorized in Ireland, New Zealand, South Africa, UK.

Active ingredients

The drug SUBLIMAZE contains one active pharmaceutical ingredient (API):

1	Fentanyl UNII MUN5LYG46H - FENTANYL CITRATE
	Fentanyl is a potent µ-opioid analgesic with rapid onset of analgesia and short duration of action. Its primary therapeutic actions are analgesia and sedation and is approximately 100-fold more potent than morphine as an analgesic. Secondary effects of fentanyl on central nervous system (CNS), respiratory and gastro-intestinal function are typical of opioid analgesics and are considered to be class effects.
	Read more about Fentanyl

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
SUBLIMAZE Solution for injection	MPI, EU: SmPC	Medicines & Healthcare Products Regulatory Agency (GB)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
N01AH01	Fentanyl	N Nervous system → N01 Anesthetics → N01A Anesthetics, general → N01AH Opioid anesthetics
Discover more medicines within N01AH01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
GB	Medicines & Healthcare Products Regulatory Agency	45227
NZ	Medicines and Medical Devices Safety Authority	1268
ZA	Health Products Regulatory Authority	B/2.9/1014, Q/2.9/0034